XML 55 R44.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidating Financial Information - Statements of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Net Cash Provided by (Used in) Operating Activities $ 86,116 $ 71,167
Cash flows from investing activities:    
Capital expenditures, net of related payables (31,301) (23,709)
Proceeds from asset sales 0 4,964
Distributions in excess of earnings from joint ventures 0 249
Distributions from subsidiaries 0 0
Proceeds from repayment of advances to subsidiaries, net 0 0
Loans to parent, net 0 0
Native American development costs (386) (760)
Investment in subsidiaries 0 0
Other, net (746) (570)
Net cash (used in) provided by investing activities (32,433) (19,826)
Cash flows from financing activities:    
Borrowings under credit agreements with original maturities of three months or less, net 10,000 20,000
Payments under credit agreements with original maturities greater than three months (48,142) (65,880)
Distributions to members and noncontrolling interests (2,485) (18,877)
Payments on derivative instruments with other-than-insignificant financing elements (1,786) (2,441)
Loans from subsidiaries, net 0 0
Payments on advances from parent, net 0 0
Capital contributions from parent 0 0
Payment of note payable (6,000) 0
Other, net (2,118) (997)
Net cash used in financing activities (50,531) (68,195)
Cash and cash equivalents:    
Increase (decrease) in cash and cash equivalents 3,152 (16,854)
Balance, beginning of period 115,346 122,702
Balance, end of period 118,498 105,848
Supplemental cash flow disclosures:    
Cash paid for interest, net of amounts capitalized 38,212 39,589
Capital expenditures incurred but not yet paid 18,213 12,472
Parent [Member]    
Net Cash Provided by (Used in) Operating Activities (36,330) (34,505)
Cash flows from investing activities:    
Capital expenditures, net of related payables (1,706) (5,540)
Proceeds from asset sales   13
Distributions in excess of earnings from joint ventures   0
Distributions from subsidiaries 7,308 7,052
Proceeds from repayment of advances to subsidiaries, net 31,556 44,697
Loans to parent, net 0 0
Native American development costs 0 0
Investment in subsidiaries (478) (29)
Other, net 15 10
Net cash (used in) provided by investing activities 36,695 46,203
Cash flows from financing activities:    
Borrowings under credit agreements with original maturities of three months or less, net 10,000 20,000
Payments under credit agreements with original maturities greater than three months (48,142) (65,090)
Distributions to members and noncontrolling interests (364) (17,077)
Payments on derivative instruments with other-than-insignificant financing elements (1,786) (1,989)
Loans from subsidiaries, net 53,692 47,909
Payments on advances from parent, net 0 0
Capital contributions from parent 0 0
Payment of note payable 0  
Other, net (1,815) (500)
Net cash used in financing activities 11,585 (16,747)
Cash and cash equivalents:    
Increase (decrease) in cash and cash equivalents 11,950 (5,049)
Balance, beginning of period 5,897 13,554
Balance, end of period 17,847 8,505
Supplemental cash flow disclosures:    
Cash paid for interest, net of amounts capitalized 37,200 38,230
Capital expenditures incurred but not yet paid 4,777 5,149
Guarantor Subsidiaries [Member]    
Net Cash Provided by (Used in) Operating Activities 117,461 101,454
Cash flows from investing activities:    
Capital expenditures, net of related payables (29,407) (17,857)
Proceeds from asset sales   4,255
Distributions in excess of earnings from joint ventures   249
Distributions from subsidiaries 2,120 1,800
Proceeds from repayment of advances to subsidiaries, net 0 0
Loans to parent, net (53,692) (47,909)
Native American development costs (386) (760)
Investment in subsidiaries 0 0
Other, net (274) (551)
Net cash (used in) provided by investing activities (81,639) (60,773)
Cash flows from financing activities:    
Borrowings under credit agreements with original maturities of three months or less, net 0 0
Payments under credit agreements with original maturities greater than three months 0 0
Distributions to members and noncontrolling interests (7,308) (7,052)
Payments on derivative instruments with other-than-insignificant financing elements 0 (452)
Loans from subsidiaries, net 0 0
Payments on advances from parent, net (31,556) (44,697)
Capital contributions from parent 0 0
Payment of note payable (6,000)  
Other, net (303) (497)
Net cash used in financing activities (45,167) (52,698)
Cash and cash equivalents:    
Increase (decrease) in cash and cash equivalents (9,345) (12,017)
Balance, beginning of period 105,837 104,575
Balance, end of period 96,492 92,558
Supplemental cash flow disclosures:    
Cash paid for interest, net of amounts capitalized 31 486
Capital expenditures incurred but not yet paid 13,369 7,253
Parent and Guarantor Eliminations [Member]    
Net Cash Provided by (Used in) Operating Activities 0 0
Cash flows from investing activities:    
Capital expenditures, net of related payables 0 0
Proceeds from asset sales   0
Distributions in excess of earnings from joint ventures   0
Distributions from subsidiaries (7,308) (7,052)
Proceeds from repayment of advances to subsidiaries, net (31,556) (44,697)
Loans to parent, net 53,692 47,909
Native American development costs 0 0
Investment in subsidiaries 0 0
Other, net 0 0
Net cash (used in) provided by investing activities 14,828 (3,840)
Cash flows from financing activities:    
Borrowings under credit agreements with original maturities of three months or less, net 0 0
Payments under credit agreements with original maturities greater than three months 0 0
Distributions to members and noncontrolling interests 7,308 7,052
Payments on derivative instruments with other-than-insignificant financing elements 0 0
Loans from subsidiaries, net (53,692) (47,909)
Payments on advances from parent, net 31,556 44,697
Capital contributions from parent 0 0
Payment of note payable 0  
Other, net 0 0
Net cash used in financing activities (14,828) 3,840
Cash and cash equivalents:    
Increase (decrease) in cash and cash equivalents 0 0
Balance, beginning of period 0 0
Balance, end of period 0 0
Supplemental cash flow disclosures:    
Cash paid for interest, net of amounts capitalized 0 0
Capital expenditures incurred but not yet paid 0 0
Parent and Guarantor Subsidiaries [Member]    
Net Cash Provided by (Used in) Operating Activities 81,131 66,949
Cash flows from investing activities:    
Capital expenditures, net of related payables (31,113) (23,397)
Proceeds from asset sales   4,268
Distributions in excess of earnings from joint ventures   249
Distributions from subsidiaries 2,120 1,800
Proceeds from repayment of advances to subsidiaries, net 0 0
Loans to parent, net 0 0
Native American development costs (386) (760)
Investment in subsidiaries (478) (29)
Other, net (259) (541)
Net cash (used in) provided by investing activities (30,116) (18,410)
Cash flows from financing activities:    
Borrowings under credit agreements with original maturities of three months or less, net 10,000 20,000
Payments under credit agreements with original maturities greater than three months (48,142) (65,090)
Distributions to members and noncontrolling interests (364) (17,077)
Payments on derivative instruments with other-than-insignificant financing elements (1,786) (2,441)
Loans from subsidiaries, net 0 0
Payments on advances from parent, net 0 0
Capital contributions from parent 0 0
Payment of note payable (6,000)  
Other, net (2,118) (997)
Net cash used in financing activities (48,410) (65,605)
Cash and cash equivalents:    
Increase (decrease) in cash and cash equivalents 2,605 (17,066)
Balance, beginning of period 111,734 118,129
Balance, end of period 114,339 101,063
Supplemental cash flow disclosures:    
Cash paid for interest, net of amounts capitalized 37,231 38,716
Capital expenditures incurred but not yet paid 18,146 12,402
Non-Guarantor Subsidiaries [Member]    
Net Cash Provided by (Used in) Operating Activities 4,985 4,218
Cash flows from investing activities:    
Capital expenditures, net of related payables (188) (312)
Proceeds from asset sales   696
Distributions in excess of earnings from joint ventures   0
Distributions from subsidiaries 0 0
Proceeds from repayment of advances to subsidiaries, net 0 0
Loans to parent, net 0 0
Native American development costs 0 0
Investment in subsidiaries 0 0
Other, net (487) (29)
Net cash (used in) provided by investing activities (675) 355
Cash flows from financing activities:    
Borrowings under credit agreements with original maturities of three months or less, net 0 0
Payments under credit agreements with original maturities greater than three months 0 (790)
Distributions to members and noncontrolling interests (4,241) (3,600)
Payments on derivative instruments with other-than-insignificant financing elements 0 0
Loans from subsidiaries, net 0 0
Payments on advances from parent, net 0 0
Capital contributions from parent 478 29
Payment of note payable 0  
Other, net 0 0
Net cash used in financing activities (3,763) (4,361)
Cash and cash equivalents:    
Increase (decrease) in cash and cash equivalents 547 212
Balance, beginning of period 3,612 4,573
Balance, end of period 4,159 4,785
Supplemental cash flow disclosures:    
Cash paid for interest, net of amounts capitalized 981 873
Capital expenditures incurred but not yet paid 67 70
Eliminations [Member]    
Net Cash Provided by (Used in) Operating Activities 0 0
Cash flows from investing activities:    
Capital expenditures, net of related payables 0 0
Proceeds from asset sales   0
Distributions in excess of earnings from joint ventures   0
Distributions from subsidiaries (2,120) (1,800)
Proceeds from repayment of advances to subsidiaries, net 0 0
Loans to parent, net 0 0
Native American development costs 0 0
Investment in subsidiaries 478 29
Other, net 0 0
Net cash (used in) provided by investing activities (1,642) (1,771)
Cash flows from financing activities:    
Borrowings under credit agreements with original maturities of three months or less, net 0 0
Payments under credit agreements with original maturities greater than three months 0 0
Distributions to members and noncontrolling interests 2,120 1,800
Payments on derivative instruments with other-than-insignificant financing elements 0 0
Loans from subsidiaries, net 0 0
Payments on advances from parent, net 0 0
Capital contributions from parent (478) (29)
Payment of note payable 0  
Other, net 0 0
Net cash used in financing activities 1,642 1,771
Cash and cash equivalents:    
Increase (decrease) in cash and cash equivalents 0 0
Balance, beginning of period 0 0
Balance, end of period 0 0
Supplemental cash flow disclosures:    
Cash paid for interest, net of amounts capitalized 0 0
Capital expenditures incurred but not yet paid $ 0 $ 0